Table 3 The Anti-inflammatory activity (R.B.C. Membrane stabilization %) and antioxidant activities (free radical scavenging %) of the synthesized compounds.
Compound | R.B.Cs membrane stabilization (%) | Free Radical Scavenging (%) |
|---|---|---|
1a | 34.09 ± 0.87 | 22.10 ± 0.74 |
1b | 22.50 ± 1.35 | 14.54 ± 0.97 |
1c | 30.08 ± 2.01 | 11.85 ± 0.41 |
1d | 35.27 ± 1.48 | 41. 75 ± 1.56 |
2a | 58.91 ± 0.83 | 51.28 ± 1.22 |
2b | 56.33 ± 1.28 | 50.03 ± 1.79 |
2c | 63.20 ± 0.57 | 60.38 ± 1.85 |
2d | 39.42 ± 1.23 | 18.52 ± 0.29 |
3a | 50.86 ± 0.92 | 34.50 ± 0.51 |
3b | 58.78 ± 1.61 | 38.97 ± 0.67 |
3c | 61.24 ± 2.12 | 40.54 ± 1.30 |
3d | 44.75 ± 1.65 | 36.18 ± 1.07 |
4a | 64.82 ± 1.77 | 61.02 ± 1.16 |
4b | 69.33 ± 1.42 | 71.34 ± 0.86 |
4c | 65.74 ± 1.33 | 53.42 ± 0.73 |
4d | 60.05 ± 2.24 | 49.31 ± 0.68 |
5a | 45.89 ± 1.90 | 39.75 ± 0.92 |
5b | 52.35 ± 1.18 | 48.11 ± 0.64 |
5c | 57.20 ± 0.86 | 40.99 ± 0.81 |
5d | 60.19 ± 1.65 | 42.15 ± 0.75 |
6a | 18.50 ± 0.34 | 11.40 ± 0.48 |
6b | 32.40 ± 0.82 | 9.66 ± 0.58 |
6c | 24.18 ± 0.71 | 8.22 ± 0.34 |
6d | 18.92 ± 0.43 | 10.36 ± 0.59 |
7a | 66.85 ± 0.75 | 54.19 ± 1.26 |
7b | 64.28 ± 1.83 | 58.48 ± 0.96 |
7c | 51.24 ± 1.37 | 48.62 ± 1.17 |
7d | 58.70 ± 0.42 | 52.33 ± 0.72 |
8a | 32.44 ± 0.76 | 36.75 ± 0.83 |
8b | 57.31 ± 1.18 | 44.32 ± 1.08 |
8c | 50.04 ± 1.66 | 42.88 ± 0.73 |
8d | 48.44 ± 1.07 | 43.05 ± 0.79 |
9a | 51.28 ± 1.39 | 45.02 ± 1.31 |
9b | 30.51 ± 0.77 | 14.46 ± 0.34 |
9c | 28.13 ± 0.53 | 18.23 ± 0.78 |
9d | 63.42 ± 0.80 | 55.24 ± 1.37 |
10a | 55.83 ± 0.46 | 50.98 ± 0.66 |
10b | 52.37 ± 0.94 | 46.75 ± 0.49 |
10c | 72.62 ± 2.01 | 77.56 ± 1.80 |
11a | 70.05 ± 1.90 | 69.86 ± 1.33 |
11b | 69.38 ± 1.70 | 70.15 ± 0.84 |
11c | 67.32 ± 1.44 | 66.17 ± 1.19 |
Reference drugs | Aspirin (acetylsalicylic acid) 76.33 ± 1.89 | Ascorbic acid 81.36 ± 1.72 |